K902786 is an FDA 510(k) clearance for the MILENIA (TM) LH. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.
Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on October 12, 1990 after a review of 108 days - within the typical 510(k) review window.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.
View all Diagnostic Products Corp. devices